Loading...

Cheryl Saenz

TitleClinical Professor
InstitutionUniversity of California San Diego
DepartmentReproductive Medicine
Address9500 Gilman Drive #0987
La Jolla CA 92093
Phone858-822-6275
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hillman RT, Saenz C, McHale MT, Plaxe SC. Fertility preservation and survival among young women with early ovarian cancer living in US counties with gynecologic oncologist services. Int J Gynaecol Obstet. 2017 May; 137(2):157-163. PMID: 28170079.
      View in: PubMed
    2. Delaney JR, Patel CB, Willis KM, Haghighiabyaneh M, Axelrod J, Tancioni I, Lu D, Bapat J, Young S, Cadassou O, Bartakova A, Sheth P, Haft C, Hui S, Saenz C, Schlaepfer DD, Harismendy O, Stupack DG. Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer. Nat Commun. 2017 Feb 15; 8:14423. PMID: 28198375.
      View in: PubMed
    3. Noticewala SS, Li N, Williamson CW, Hoh CK, Shen H, McHale MT, Saenz C, Einck J, Plaxe S, Vaida F, Yashar CM, Mell LK. Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2017 03 15; 97(4):797-805. PMID: 28244416.
      View in: PubMed
    4. Mell LK, Sirák I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, McHale MT, Xu R, Honerkamp-Smith G, Carmona R, Wright M, Williamson CW, Kasaová L, Li N, Kry S, Michalski J, Bosch W, Straube W, Schwarz J, Lowenstein J, Jiang SB, Saenz C, Plaxe S, Einck J, Khorprasert C, Koonings P, Harrison T, Shi M, Mundt AJ. Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2). Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):536-545. PMID: 28126303.
      View in: PubMed
    5. Taylor KN, McHale MT, Saenz C, Plaxe SC. Diagnosis and treatment of Clostridium difficile (C. diff) colitis: Review of the literature and a perspective in gynecologic oncology. Gynecol Oncol. 2017 Feb; 144(2):428-437. PMID: 27876339.
      View in: PubMed
    6. Vavinskaya V, Baumgartner JM, Ko A, Saenz C, Valasek MA. Low-Grade Appendiceal Mucinous Neoplasm Involving the Endometrium and Presenting with Mucinous Vaginal Discharge. Case Rep Obstet Gynecol. 2016; 2016:6841989. PMID: 27843660.
      View in: PubMed
    7. Tierney NM, Saenz C, McHale M, Ward K, Plaxe S. Industry Payments to Obstetrician-Gynecologists: An Analysis of 2014 Open Payments Data. Obstet Gynecol. 2016 Feb; 127(2):376-82. PMID: 26942368.
      View in: PubMed
    8. Shah NR, Ward KK, Plaxe SC, Saenz C, McHale MT. Urinary diversions: A time to enrich surgical training? Gynecol Oncol. 2016 Jan; 140(1):120-3. PMID: 26556767.
      View in: PubMed
    9. Kurnit KC, Ward KK, McHale MT, Saenz C, Plaxe SC. Increased prevalence of comorbid conditions in women with uterine cancer. Gynecol Oncol. 2015 Sep; 138(3):731-4. PMID: 26160712.
      View in: PubMed
    10. Barrett CL, DeBoever C, Jepsen K, Saenz C, Carson DA, Frazer KA. Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy. Proc Natl Acad Sci U S A. 2015 Jun 09; 112(23):E3050-7. PMID: 26015570; PMCID: PMC4466751.
    11. Hillman RT, Ward K, Saenz C, McHale M, Plaxe S. Barriers prevent patient access to personalized therapies identified by molecular tumor profiling of gynecologic malignancies. J Pers Med. 2015 May 21; 5(2):165-73. PMID: 26011384; PMCID: PMC4493494.
    12. Simpson DR, Scanderbeg DJ, Carmona R, McMurtrie RM, Einck J, Mell LK, McHale MT, Saenz C, Plaxe SC, Harrison T, Mundt AJ, Yashar CM. Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):150-7. PMID: 26130230.
      View in: PubMed
    13. Ward KK, Roncancio AM, Shah NR, Davis MA, Saenz C, McHale MT, Plaxe SC. Bariatric surgery decreases the risk of uterine malignancy. Gynecol Oncol. 2014 Apr; 133(1):63-6. PMID: 24680593.
      View in: PubMed
    14. Mell LK, Carmona R, Gulaya S, Lu T, Wu J, Saenz C, Vaida F. Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: a population-based study. J Natl Cancer Inst. 2013 Nov 06; 105(21):1656-66. PMID: 24123960.
      View in: PubMed
    15. Ward KK, Roncancio AM, Shah NR, Davis MA, Saenz C, McHale MT, Plaxe SC. The risk of uterine malignancy is linearly associated with body mass index in a cohort of US women. Am J Obstet Gynecol. 2013 Dec; 209(6):579.e1-5. PMID: 23938608.
      View in: PubMed
    16. Kim JS, Ward KK, Shah NR, Saenz C, McHale MT, Plaxe SC. Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics. Support Care Cancer. 2013 Nov; 21(11):3103-7. PMID: 23839499.
      View in: PubMed
    17. Abbott Y, Shah NR, Ward KK, McHale MT, Alvarez EA, Saenz C, Plaxe SC. Use of psychosocial services increases after a social worker-mediated intervention in gynecology oncology patients. Health Soc Work. 2013 May; 38(2):113-21. PMID: 23865288.
      View in: PubMed
    18. Ballas J, Hull AD, Saenz C, Warshak CR, Roberts AC, Resnik RR, Moore TR, Ramos GA. Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta: a management paradox. Am J Obstet Gynecol. 2012 Sep; 207(3):216.e1-5. PMID: 22831808.
      View in: PubMed
    19. Liang Y, Bydder M, Yashar CM, Rose BS, Cornell M, Hoh CK, Lawson JD, Einck J, Saenz C, Fanta P, Mundt AJ, Bydder GM, Mell LK. Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):406-14. PMID: 22687195.
      View in: PubMed
    20. Ward KK, Shah NR, Saenz C, McHale MT, Alvarez EA, Plaxe SC. Changing demographics of cervical cancer in the United States (1973-2008). Gynecol Oncol. 2012 Sep; 126(3):330-3. PMID: 22668881.
      View in: PubMed
    21. Ward KK, Shah NR, Saenz C, McHale MT, Alvarez EA, Plaxe SC. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol. 2012 Aug; 126(2):176-9. PMID: 22507532.
      View in: PubMed
    22. Haripotepornkul NH, Nath SK, Scanderbeg D, Saenz C, Yashar CM. Evaluation of intra- and inter-fraction movement of the cervix during intensity modulated radiation therapy. Radiother Oncol. 2011 Mar; 98(3):347-51. PMID: 21216480.
      View in: PubMed
    23. Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz C, Kelly TF, Moore TR, Resnik R. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010 Jan; 115(1):65-9. PMID: 20027036.
      View in: PubMed
    24. Eskander RN, Scanderbeg D, Saenz C, Brown M, Yashar C. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring. Int J Gynecol Cancer. 2010 Jan; 20(1):47-53. PMID: 20130502.
      View in: PubMed
    25. Denicourt C, Saenz C, Datnow B, Cui XS, Dowdy SF. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Res. 2007 Oct 01; 67(19):9238-43. PMID: 17909030.
      View in: PubMed
    26. Snyder EL, Saenz C, Denicourt C, Meade BR, Cui XS, Kaplan IM, Dowdy SF. Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides. Cancer Res. 2005 Dec 01; 65(23):10646-50. PMID: 16322205.
      View in: PubMed
    27. Eitan R, Saenz C, Venkatraman ES, Hann L, Bach A, Gretz E, Barakat RR, Chi DS. Pilot study prospectively evaluating the use of the measurement of preoperative sonographic endometrial thickness in postmenopausal patients with endometrial cancer. Menopause. 2005 Jan-Feb; 12(1):27-30. PMID: 15668597.
      View in: PubMed
    28. Snyder EL, Meade BR, Saenz C, Dowdy SF. Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide. PLoS Biol. 2004 Feb; 2(2):E36. PMID: 14966535; PMCID: PMC340944.